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Antimicrobial policy interventions in food animal 
production in South East Asia
Flavie Goutard and colleagues call for concerted multisectoral measures through stronger 
policies to combat antimicrobial resistance
A
ntibiotics and other antimicrobial 
agents are widely used in food 
animal production for disease 
prevention and treatment in ani-
mals, to contain disease spread, 
to prevent contamination of the food chain, 
and to increase productivity.1 However, their 
wide use in humans and animals leads to 
the emergence of antimicrobial resistance, 
a general term that encompasses antibiotic 
resistance.2 In September 2016, the United 
Nations recognised the global rise of antimi-
crobial resistance as a threat to health and 
human development.3 
Antimicrobial resistance will increase 
infectious disease outbreaks, slowing 
down livestock productivity and disrupting 
international trade. Recent projections 
estimated that by 2050 global livestock 
production would fall by 3% to 8% 
each year, resulting in the decline in the 
annual global gross domestic product of 
1.1%-3.8%. Because of higher disease 
incidence, these falls will affect low income 
countries more severely, with a predicted 
rise of 6.2 to 18.7 million in the number 
of extremely poor people by 2030.4 The 
UN has called for a limit on the overuse of 
 antimicrobial agents, including in animals, 
but an evaluation of the national animal 
health systems of about 130 countries, 
performed by the World Organisation for 
Animal Health (OIE) using its performance 
veterinary services pathway tool, showed 
that more than 110 of them do not yet have 
appropriate legislation to regulate the 
import, manufacture, distribution, and 
use of antimicrobial agents. Even where 
legislation does exist and is enforced, 
antibiotics continue to be freely circulated 
as common goods, and in many countries 
they are often counterfeited.5
Several countries in the region produce 
meat and aquaculture products for 
the global market.6 The World Health 
Organization South East Asia region (SEAR: 
Bangladesh, Bhutan, Democratic People’s 
Republic of Korea, India, Indonesia, 
Maldives, Myanmar, Nepal, Sri Lanka, 
Thailand, Timor-Leste) has developed 
intensive farming systems, leading to 
the rising consumption of fertilisers, 
antibiotics, and pesticides, of which many 
farmers have limited technical knowledge. 
The lack or weakness of regulations, 
adequate policies, and implementation 
of standards for antibiotic use in the food 
animal sector, together with low standards 
of biosecurity, hygiene, and sanitation, 
have accelerated the emergence and 
dissemination of antibiotic resistance.27 
We have determined the challenges and 
requirements for policy interventions to 
combat antimicrobial resistance in food 
animal production in each of the SEAR 
countries, with a focus on antibiotic 
production and marketing, use, and 
monitoring of resistance.
Methods
We reviewed several databases (PubMed, 
Science Direct, MEDLINE, LISTA, Web of 
Sciences, Scopus, and Google Scholar) to 
search for official documents, in English 
or French, published after 2010. We con-
sulted the legislative and policy database 
(Faolex: http://faolex.fao.org/) of the Food 
and Agriculture Organization of the United 
Nations (FAO) and made contact with 
the FAO and OIE national focal points for 
veterinary products. We retrieved docu-
ments from eight countries, including 16 
legal documents and 11 policies, related 
 strategies, and action plans (table 1). For 
each document we extracted information 
on the topic (drug and medicine produc-
tion and marketing, drug and medicine 
use, antibiotic resistance surveillance and 
monitoring); the competent authority in 
charge; the type of document (policy or 
legal document); the objective(s); the key 
components and limitations. These results 
were cross checked with additional infor-
mation on policy implementation and law 
enforcement found in other non-official 
documents.28910 Specific recommendations 
are based on the reference guides published 
by WHO, OIE, and FAO.11-13
Food animal sector: trends and challenges of 
antibiotic use
Over recent decades, profound changes 
in food production and feeding regimens 
have had a major effect on the use of 
antibiotics in livestock and aquaculture 
farms. Most SEAR countries have experi-
enced considerable growth in population, 
combined with improved living standards 
for part of the population. In India, the 
national diet has radically changed, with 
increased meat consumption among the 
young urban generation.14 This growing 
demand for animal proteins has resulted 
in intensive breeding of pigs, poultry, and 
fish, with the routine use of antibiotics 
as growth promoters. Meanwhile, these 
countries still face high levels of infectious 
disease, with a lack of health advice and 
guidance in veterinary care. This, together 
with weak regulations surrounding the sale 
of antibiotics and surveillance, has led to 
the emergence, maintenance, and spread 
of antibiotic resistance.4
Policy related best practices and global 
challenges for their implementation
The region is recognising that antimicrobial 
resistance issues are critical and has moved 
to develop sound and comprehensive poli-
cies to tackle the problem. These policies 
are often in line with international stand-
ards (Codex, see box 1; OIE, see table 2) and 
trade partner requirements. However, the 
regulatory framework is often outdated and 
does not allow governments to implement 
and monitor the course of action defined 
in their policies. Furthermore, some of the 
objectives of these policies remain elusive 
and are clearly unattainable in the socio-
economic context.
Key messages
•  Key policies for tackling antimicro-
bial resistance are still lacking in
many countries in the South East Asia
region, including veterinary surveil-
lance of antimicrobial resistance and
antimicrobial use, raising awareness
among professionals and farmers,
and strengthening the national drug
regulatory authorities in the animal
health sector
•  Although bans on over-the-counter
antibiotics and use of antibiotics as
growth promoters have been intro-
duced in many countries, enforcement
remains a challenge
•  Further evidence is needed to under-
stand local barriers and to propose
viable, policy driven solutions
•  The World Health Organization, World
Organisation for Animal Health, and
the Food and Agriculture Organization
have important roles in identifying
best practices in the region to support
development of national policies
the bmj | BMJ 358:Suppl1 37
AntiMicroBiAl reSiStAnce in South eASt ASiA
Antibiotic production and marketing
All SEAR countries have sound legal 
requirements that establish a framework 
for the quality of drugs used in food ani-
mals (table 3). However, official documents 
do not specifically target antibiotic produc-
tion and marketing, and requirements for 
manufacturing and licensing are poorly 
described. Good manufacturing practices, 
as well as quality assurance and con-
trol, are compulsory in several countries, 
although only Thailand seems fully able to 
carry out official checks at every level of the 
manufacture and distribution of veterinary 
medicines. Finally, the circulation of coun-
terfeit and substandard antibiotics is poorly 
dealt with; control legislation (inspections) 
should not target solely farmers but should 
include each level of the drug marketing 
chain.16
Antibiotic use
Regulations on antibiotics in animal feed 
(for growth promotion or therapeutic use) 
and the promotion of rational antibiotic 
use in healthcare and veterinary settings 
Table 1 | List of official documents dealing with antibiotics (except antimicrobial residue surveillance and control) in the food animal production system from SEAR 
retrieved from the literature review between 2010 and 2016
Document title Year Type Development/monitoring Use Monitoring
Bangladesh
National drug policy 2005 P YES - -
Fish feed and animal feed act 2010 L - Yes -
National livestock development policy 2007 P - Yes -
National strategy for antimicrobial resistance containment (ARC) 2011 P - Yes Yes
Road map of national action plan for ARC - P - Yes Yes
The drug (control) ordinance 1982 L Yes - -
Bhutan
Medicines rules and regulation 2012 L Yes Yes -
National action plan on antimicrobial resistance (draft) 2015 P - Yes Yes
National antimicrobial policy (draft) 2015 P - Yes Yes
India
Advisory on use of antibiotics in food producing animals 2014 P - Yes -
Drugs and Cosmetics Act 1945 L Yes - -
Bureau of Indian Standards, poultry feed specification, 5th revision 1374:2007 2007 P - Yes -
Food safety and standards (contaminants, toxins, residues) regulations 2011 L - Yes -
National livestock policy 2013 P - Yes -
National policy for containment of antimicrobial resistance 2011 P Yes Yes -
Indonesia
Law No 18 on husbandry and animal health 2009 L - Yes -
Manual for prime method of animal drugs manufacturing 1999 P Yes - -
Regulation of the head of the agency of drug and food control no 27 2013 L Yes - -
Regulation of the head of the agency of drug and food control no 28 2013 L Yes Yes -
Regulation of the minister of marine affairs and fishery on fish medication 2012 L Yes - -
Terms and procedures for the issuance of animal medicine business permit 2009 L Yes - -
Myanmar
Fisheries law directive 9.96 on general product standard 1996 L - Yes -
Nepal
Drug act 1978 L Yes - -
Drug registration rules 1981 L Yes - -
National drug policy 1995 P Yes Yes -
Sri Lanka
Animal Diseases Act No 59 1992 L Yes - -
Thailand
Code of practice for control of the use of veterinary drugs 2009 L - Yes -
Drug ACT B.E.2510 (A.C. 1967) and its amendment 2001 L Yes - -
No documents were retrieved for Timor-Leste, Korea, and Maldives. L= legislation; P=policies.
Box 1: Codex texts on foodborne antimicrobial resistance related best practices for 
 resistance containment in food animal sectors—Codex Alimentarius Commission15
Guidelines for risk analysis of foodborne antimicrobial resistance (CAC/GL 77-2011, adopted 
2011)
These guidelines aim to
•  Provide science-based guidance on processes and methodology for risk analysis and its 
application to foodborne AMR [antimicrobial resistance] related to non-human use of 
antimicrobial agents
•  Assess the risk to human health associated with the presence in food and animal feed, 
including aquaculture, and the transmission through food and animal feed, of AMR 
microorganisms and determinants, to provide advice on appropriate risk management 
activities to reduce such risk
•  Address the risk associated with different sectors of antimicrobial agent use such as 
veterinary applications, plant protection or food processing
Code of practice to minimise and contain antimicrobial resistance (CAC /RCP 61-2005, 
adopted 2005)
This code provides recommendations to regulatory authorities and operators involved in 
the authorisation, manufacture, sale and supply, prescription, and use of antimicrobials in 
food producing people, in order to prevent or reduce the selection of antimicrobial resistant 
microorganisms in humans and animals.
These two texts, together with specific standards of importance to animal production, have supported the 
development of the Global Action Plan on Antimicrobial Resistance (adopted in May 2015), developed by WHO 
in collaboration with FAO and OIE.
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are clearly emerging as priorities for the 
region. Many countries have already devel-
oped policies to ban all use of antibiotics 
as growth promoters or feed additives, but 
few yet have the capacity to ensure their 
implementation (table 4). Policy inter-
ventions focus on good practices among 
health professionals and users, prescriber 
awareness, and disease prevention and 
diagnostics, while research on alternatives 
is overlooked.
Surveillance of antibiotic resistance and 
monitoring of use
While recognised as essential in provid-
ing the necessary data to fight effectively 
against antibiotic resistance, surveillance 
in the food animal sector is at a prelimi-
nary stage of development in the region 
(table 5). Most of the updated documents 
for surveillance of antibiotic use and 
antibiotic resistance concentrate only on 
humans, without considering the animal 
health sector. Ideally, policies should 
drive the development of surveillance of 
the use of antibiotics for terrestrial and 
aquatic animal health (and plant health), 
on resistance in clinical isolates from dis-
eased animals, and in commensal and 
zoonotic bacteria hosted by food produc-
ing animals.
Priority actions for best practice policies at 
regional level
At the time of writing, all but one country 
in the region has developed and finalised 
a national action plan for the containment 
of antimicrobial resistance in line with the 
global action plan endorsed by the World 
Health Assembly in 2015.11 Currently, 
only two countries have had their national 
action plan endorsed by the highest level 
of the government. Here, we outline prior-
ity actions for regions to design and imple-
ment.
Coordinated regional collaboration for better 
food and health security
Priority should be placed on strengthening 
the regional One Health tripartite partner-
ship (FAO, OIE, and WHO), establishing 
an antimicrobial resistance regional sec-
retariat to focus on changes in policy and 
practices expected at country level. Its 
main contribution would be to provide a 
mechanism that facilitates and empow-
ers multisectoral collaboration to combat 
antibiotic resistance in food animal pro-
duction. A synergistic approach through 
a joint regional action plan and continu-
ous communication between regional 
partners would have a trickle-down effect 
on SEAR nations. Joint understanding of 
risks, activities, and recommendations 
issued by the regional tripartite partner-
ship would drive the organisations’ coun-
try offices and their respective national 
counterparts to communicate, exchange, 
and collaborate.
A regional secretariat could organise 
the joint monitoring of progress towards 
implementation of a national action plan, 
promote best practices on policies, and 
provide evidence to deal with country 
specific barriers and challenges concerning 
policy enforcement. Actions would enable 
emphasis to be placed on best practices 
within policies, with the rules and 
Table 3 | Country specific analysis of policies, legislation, and regulation for antibiotic production and marketing
Topic Main findings/objectives Gaps identified Country specific features
General Existence of official documents framing antimicrobial 
production and marketing in 7 countries (4 policy documents 
and 11 legal instruments) 
Joint documents for human and veterinary sectors, issued by 
the public health authorities
Antibiotic management poorly addressed as a 
specific issue 
Legislation outdated regarding the emerging 
issue of antibiotic resistance  
Inadequacy between policy interventions and 
available legal instruments 
Drugs management mainly addressed in human 
sector
India: specific document dealing with antibiotic 
management (human drugs) 
Indonesia, Thailand: specific documents for 
veterinary drugs 
Licensing requirements more or less strict 
depending on the country
Drug 
commercialisation
Mandatory registration and authorisation 
Administrative and quality requirements for authorisation, 
Authorisation cancellation or suspension conditions, 
Active list for illegal substances
Licensing criteria and procedure poorly 
described
Nepal, Bangladesh: science based assessment 
of drugs before introduction to market
Drug production 
and manufacture
Compulsory registration for companies, mandatory 
implementation and compliance with good manufacturing 
practice, quality assurance and control
Official control measures carried out by 
competent authorities not commonly addressed
Bhutan, Bangladesh, India, Thailand: provisions 
for inspections of manufacturers
Drug distribution, 
sale, and storage
Mandatory authorisation for business operators 
Mandatory compliance with quality and ethical requirements 
Quality assessment, licensing of veterinary drugs 
Specific requirement for importation and exportation 
Assessment of veterinary drug quality before being put on 
the market
Official control measures carried out by 
competent authorities not commonly addressed
Bhutan, Bangladesh, India, Thailand: provisions 
for inspections of sellers
Table 2 | OIE standards and guidelines related to antimicrobial agents and veterinary public health12
Chapter Guideline Version
Terrestrial Animal Health Code
Chapter 6.7 Harmonisation of national antimicrobial resistance surveillance and monitoring programmes Revision adopted in 2012
Chapter 6.8 Monitoring of the quantities and usage patterns of antimicrobial agents used in food producing animals Revision adopted in 2012
Chapter 6.9 Responsible and prudent use of antimicrobial agents in veterinary medicine Revision adopted in 2012
Chapter 6.10 Risk analysis for antimicrobial resistance arising from the use of antimicrobials in animals Revision adopted in 2014
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals
Chapter 3.1 Laboratory methodologies for bacterial antimicrobial susceptibility testing Current version adopted in May 2012
Aquatic Animal Health Code
Chapter 6.2 Principles for responsible and prudent use of antimicrobial agents in aquatic animals Adopted in 2011
Chapter 6.3 Monitoring of the quantities and usage patterns of antimicrobial agents used in aquatic animals Adopted in 2012
Chapter 6.4 Development and harmonisation of national antimicrobial resistance surveillance and monitoring  
programmes for aquatic animals
Adopted in 2012
Chapter 6.5 Risk analysis for antimicrobial resistance arising from the use of antimicrobial agents in aquatic animals Adopted in 2015
List of antimicrobial agents of veterinary importance
OIE List of antimicrobial agents of veterinary importance Revision adopted in 2015
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legislation rooted in a sound evidence base 
that is sufficiently flexible to accommodate 
different contexts.17
One Health approach: the way forward
Combating antibiotic resistance is a com-
plex process in which interventions in a 
single sector cannot be effective in tack-
ling the problem as a whole. Integrated 
approaches, which identify the roles and 
relative importance of each compartment 
(human, animal, and environment), are key 
to understanding and combating antibiotic 
resistance. Above all, an integrated policy 
is required and could be operated under 
the One Health umbrella. As resistant 
organisms exist in humans, animals, food, 
and the environment—and the main driver 
of this resistance is antimicrobial use—a 
One Health conceptual framework for sur-
veillance and control can be promoted.18 
Moreover, in a region such as SEAR con-
sisting of many and varied socioeconomic 
environments, policies should be context 
dependent and based on economic data, 
to avoid a negative effect on vulnerable 
populations and social inequity. Within 
the region, a One Health approach has been 
used for some policy decisions (table 4, 
table 5). For example, documents covering 
drug production and marketing are often 
common to human and veterinary sectors, 
and  several countries are developing their 
national action plans by including multiple 
sectors.
Increase antibiotic resistance surveillance 
and monitoring of use
Surveillance that generates reliable data is 
essential for sound global strategies and 
public health actions to contain antibi-
otic resistance and is urgently needed to 
improve policy development in SEAR.1920 
Veterinary services are trying to stretch 
their resources and capacities beyond the 
ongoing surveillance of transboundary 
animal diseases to include antibiotic resist-
ance surveillance, which requires a mainly 
active form of surveillance. There are vari-
ous approaches to surveillance: drug resist-
ance of pathogenic or commensal bacteria, 
antibiotic use for disease treatment, and 
non-therapeutic use. Understanding what 
each approach entails will allow the coun-
tries to prioritise and eventually help shape 
policies.
One priority action for the region 
should be to set-up an integrated 
surveillance system for drug resistant 
pathogens, together with a harmonised 
monitoring system of antibiotic use. 
The standardisation of data sharing and 
data collection methods and antibiotic 
resistance testing, between sectors and 
countries, should enable each government 
to implement early effective control 
measures and to monitor the effectiveness 
of their policies.
Sharing standards for antibiotic use in animal 
food production
Since the introduction of the global action 
plan on antimicrobial resistance, there 
has been an international agreement to 
ban antibiotics as growth promoters in 
the absence of risk analysis.11 Several 
SEAR countries have already banned 
antibiotic additives in feed. However, food 
safety standards used for export products 
are often higher than those for products 
intended only for local  consumption, 
Table 4 | Country specific analysis of policies, legislation, and regulation for antibiotic use
Topic Main findings/objectives Gaps identified Country specific features
General Existence of official documents framing 
antimicrobial use in 7 countries (9 policy 
documents and 7 legal instruments) 
Documents in line with international standards 
and trade partner requirements
Inadequacy between policy interventions 
and available legal instruments 
Disproportionate national policy 
objectives regarding the local 
socioeconomic context
India, Nepal, Bhutan: national roadmaps to ban non-
therapeutic use of antibiotics in feed but no regulatory 
framework for implementation
Appropriate and prudent 
use of antibiotics
Development of good pharmacist practices 
Ban on over-the-counter antibiotics 
Development of standard treatment guidelines 
Promotion of AST before prescription 
Licensing of veterinary pharmacists 
Education and awareness of sellers and users
Policy interventions focusing on: 
good practices, users and prescribers’ 
awareness, disease prevention and 
spread 
Research of new antibiotics and 
alternatives is poorly addressed
Indonesia, Thailand: Code of practices for control of veterinary 
drugs use (in line with Codex) 
Bangladesh, Bhutan, India, Thailand, and Nepal: intersectoral 
policies to contain AMR. 
India: regulation for judicious use by veterinarians, but no 
provisions for implementation and monitoring
Regulation of veterinary 
medicines and medicated 
feed usage
Prohibition on use of antibiotics in feed as growth 
promoter 
Control enforcement for irrational and non-
therapeutic/subtherapeutic use 
Improvement of labelling and traceability 
Ban on certain antibiotics critical to human health
Antibiotics still used as growth promoters 
or in animal feed for therapeutic use 
Lack of official controls to ensure law 
enforcement
Sri Lanka, Maldives: ban of all antibiotics as growth promoters 
and in medicated feed 
Thailand: ban of all antibiotics as growth promoters, total 
prohibition of medicated feed in aquaculture, regular official 
controls on use 
Bangladesh: ban on antibiotics as feed additive 
Indonesia, India, Thailand: restriction on the use of antibiotics 
intended for human treatment
AMR=antimicrobial resistance; AST=antimicrobial susceptibility testing.
Table 5 | Country specific analysis of policies, legislation, and regulation for antibiotic resistance surveillance and monitoring of antimicrobial 
use
Topic Main findings Gaps identified Country specific features
General Existence of official documents framing AMR or 
monitoring of use in 2 countries (4 policy documents) 
Development of documents in line with international 
standards (OIE, European regulation)
Topic poorly addressed in official documents 
No legal framework to implement the 
monitoring objectives when they exist 
Lack of cross-sectoral approach in the 
updated documents
Bangladesh: development of a national strategy to 
contain AMR, including monitoring of resistance and use 
Bhutan: draft of integrated surveillance system, in line 
with the One Health concept
AMU monitoring Monitoring use and prescribing patterns,- 
Assessment of non-therapeutic use in veterinary sector, 
Monitoring and evaluation of impact of promotion on 
consumption, 
Data dissemination to users and prescribers
Thailand: project developing a policy for monitoring use 
India: monitoring of AMR in food animals not yet part of 
the national policy on AMR containment.
ABR surveillance Appropriate laboratory capabilities and networking 
Development of surveillance protocol 
Harmonised AST results reporting system 
Prioritisation of bacteria to be monitored 
Dissemination of data to stakeholders 
Development of a national strains repository
Thailand: development of a national veterinary 
surveillance system for AMR in line with European Union 
and OIE requirements but no legal framework yet 
Nepal: AMR monitoring of animal samples along AMR 
surveillance in hospitals
ABR=antibiotic resistance; AMR=antimicrobial resistance; AMU=antimicrobial use; AST=antimicrobial susceptibility testing.
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which may be poorly enforced. WHO, 
OIE, and FAO should support SEAR coun-
tries to achieve a total ban on antibiot-
ics for growth promotion by developing 
 measures (biosecurity, farming practices, 
access to diagnostics, alternatives to anti-
biotics) based on cost effectiveness stud-
ies to preserve farmers’ productivity.421 
Initiatives to include feed industries and 
to enhance consumer awareness should 
be promoted.
Meanwhile, monitoring of antibiotic 
use in food animals should be enforced to 
detect any increase in animal diseases and 
to avoid farmers reaching for poor quality 
antibiotics. Particular attention should 
be given to the potential effect of new or 
changed regulatory policies on producers 
and consumers.17 The tripartite alliance 
could propose standardised assessment 
of benefits, costs, and effectiveness of 
reforms, to ensure the development of 
tailored solutions taking into account 
specific political, economic, and social 
factors.22
Understanding pathways of antibiotic 
resistance transmission and drivers of 
antibiotic use
Risk analysis, as recommended by the 
Codex Alimentarius and OIE guide-
lines,121315 is an essential tool to evaluate 
the risk to human health of antimicrobial 
resistance transmission from animal feed, 
to identify risk mitigation strategies, and 
to communicate on the complexity of this 
risk and the actions to be taken. However, 
risk analyses mainly focus on the risk of 
introducing new veterinary drugs on to 
national markets. Critical data on risk fac-
tors for the emergence and transmission 
of resistance and pathways of transmis-
sion of resistant pathogens or resistance 
genomes (foods, environments, contacts) 
are still fragmented. WHO, OIE, and FAO 
have an important role in providing more 
examples of risk analysis studies to assess 
the potential effect of the emergence and 
transmission of antimicrobial resistance 
on animal, human, and environmen-
tal health, including technical support 
to deal with risk management options, 
stakeholders communication, and the 
perception of risk by end users. Educa-
tional efforts for providers—for example, 
veterinarians and farmers—must be con-
tinuous, and appropriate materials and 
effective communication strategies must 
be developed.23
Conclusion
SEAR is lagging behind other parts of 
the world regarding the introduction of 
policies to combat antibiotic resistance, 
including surveillance, training of profes-
sionals and farmers, and the establishment 
of independent national drug regulatory 
authorities. Given the political and eco-
nomic context, many countries have been 
unable to enforce policies that are in place, 
including bans on over-the-counter drugs 
and growth promoters. The reasons for 
this include low awareness, competing 
priorities and costs of policy, and a limited 
understanding of the relation between 
resistance in animals, humans, and the 
environment. Tackling all these issues 
will lay a solid ground for policy and its 
enforcement. The One Health approach, 
driven by WHO, OIE, and FAO, will facili-
tate the development of global actions 
across sectors, while recognising specific 
environmental constraints of each country 
in the region.17
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